Reta + Cagrilintide Blend (5mg/5mg)

This research blend combines Retatrutide and Cagrilintide, two advanced metabolic research compounds studied for their complementary effects on appetite regulation, energy balance, and weight management signaling pathways. Together, they are commonly researched for synergistic activity involving GLP-1, GIP, glucagon, and amylin receptor pathways.

Product Specifications:

• Type: Multi-pathway metabolic research blend
• Purity: ≥ 98% (HPLC-tested)
• Form: Lyophilized peptide blend
• Solvent Compatibility: Bacteriostatic water
• Storage: Refrigerate after reconstitution

Key Research Characteristics:

• Studied for appetite regulation and satiety signaling
• Investigated for synergistic metabolic pathway activation
• Supports research involving energy expenditure and body composition
• Combines incretin and amylin pathway activity in one formulation
• Explored in advanced metabolic and obesity-related research models

Scientific Background:
Retatrutide is studied for its multi-receptor agonist activity involving GLP-1, GIP, and glucagon pathways, while Cagrilintide is a long-acting amylin analog researched for appetite and gastric-emptying modulation. Combined, these compounds are investigated for enhanced metabolic signaling and extended satiety effects in controlled laboratory settings.

Handling and Reconstitution:

• Reconstitute with bacteriostatic water
• Gently swirl until fully dissolved
• Do not shake vigorously
• Store refrigerated after mixing

Storage:

• Lyophilized: store in a cool, dry place
• Reconstituted: store refrigerated and use within recommended stability window

Legal Notice:
For laboratory research use only. Not for human or veterinary use.